Fig. 1From: TMT-based quantitative proteomics reveals the targets of andrographolide on LPS-induced liver injuryThe cell viability of Andro on LMH cells. LMH cells were treated with different concentrations of Andro (0, 1, 5, 10, 20, 50, 100, 200 and 400 µM) for different time points (0, 12, 24, 48, 72 and 96 h), cell viability was measured using the CCK8 assay. (* P < 0.05, ** P < 0.01, *** P < 0.001 vs. 0 µM)Back to article page